rivaroxaban,apixaban
bayer,bms,pfizer,janssen
['rivaroxaban', 'apixaban']
oscar-us-h2h observational study comparing rivaroxaban to apixaban for the management of cancer-associated-thrombosis showed that both are effective and safe. no statistical difference in any outcomes was observed after 3 or 6 months of follow up. #ash22 